LRIG1 combined with cisplatin enhances bladder cancer lesions via a novel pathway
Zhangqun Ye(Tongji Hospital)
Cited by 12
Related Papers
Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer
|Clinical Cancer Research|2016|125
XIST Inhibition Attenuates Calcium Oxalate Nephrocalcinosis‐Induced Renal Inflammation and Oxidative Injury via the miR‐223/NLRP3 Pathway
|Oxidative Medicine and Cellular Longevity|2021|69
Huachansu suppresses human bladder cancer cell growth through the Fas/Fasl and TNF- alpha/TNFR1 pathway in vitro and in vivo
|Journal of Experimental & Clinical Cancer Research|2015|66
miR-3619-5p inhibits prostate cancer cell growth by activating CDKN1A expression
|Oncology Reports|2016|56